Abstract
Dermatologic TherapyVolume 32, Issue 6 e13107 Therapeutic Hotline: Letter Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma Iris Zalaudek, Corresponding Author iris.zalaudek@gmail.com Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy Correspondence Iris Zalaudek, Maggiore Hospital of Trieste, Piazza dell'Ospitale 1, 34100 Trieste, Italy. Email: iris.zalaudek@gmail.comSearch for more papers by this authorPaola Corneli, orcid.org/0000-0001-5072-7695 Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorSibil Vernoni, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorDahlia Fedele, Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, ItalySearch for more papers by this authorGiovanni Papa, Skin Cancer Unit, Department of Plastic Surgery, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorClaudio Conforti, orcid.org/0000-0001-5126-8873 Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorChiara Retrosi, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorRoberta Vezzoni, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorSerena Fagotti, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorMichela Longone, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorEleonora Farinazzo, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorNicola di Meo, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorMaria A. Pizzichetta, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy Department of Medical Oncology-Preventive Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, ItalySearch for more papers by this author Iris Zalaudek, Corresponding Author iris.zalaudek@gmail.com Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy Correspondence Iris Zalaudek, Maggiore Hospital of Trieste, Piazza dell'Ospitale 1, 34100 Trieste, Italy. Email: iris.zalaudek@gmail.comSearch for more papers by this authorPaola Corneli, orcid.org/0000-0001-5072-7695 Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorSibil Vernoni, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorDahlia Fedele, Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, ItalySearch for more papers by this authorGiovanni Papa, Skin Cancer Unit, Department of Plastic Surgery, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorClaudio Conforti, orcid.org/0000-0001-5126-8873 Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorChiara Retrosi, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorRoberta Vezzoni, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorSerena Fagotti, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorMichela Longone, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorEleonora Farinazzo, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorNicola di Meo, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, ItalySearch for more papers by this authorMaria A. Pizzichetta, Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy Department of Medical Oncology-Preventive Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, ItalySearch for more papers by this author First published: 08 October 2019 https://doi.org/10.1111/dth.13107Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume32, Issue6November/December 2019e13107 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
